Hello Skier,

#1 (And most important of the two), Thank you for not Resting In Peace.
#2 Thank you for bringing up SAS.

I trade for a family member who does not have a Canadian account.
Therefore, my purchases for Canadian securities are in the OTC market in the USA.
Usually, this only causes the inconvenience of sometimes slightly wider spreads.

For some unfathomable reason, of the hundred or so Canadian stocks I’ve ever
looked up for OTC symbols, SAS was the only one not to have one. However,
being that you’ve brought the company to my attention (again), I looked it up again.
I was pleasantly surprised to discover it finally does trade OTC (symbol STADF).

Yesterday, when I posted my message with the wonderful BRD assays, I hadn’t
realized the previous day the company had already issued a press release with the
43-101 resource estimate of those assays. That report did not increase BRD’s total
ounces (and reduce the in situ cost per ounce) as much as I had anticipated.

As follows are the in situ comparison costs (in USD) of CRK, SAS, and BRD derived
from Friday’s (USA) closing stock prices.

$27.66 oz = CRK
$69.44 oz = SAS
$71.60 oz = BRK

I’m a numbers guy. But I’m not so closed-minded that a few dollars difference makes
any real difference to me compared to the great many all important other factors.

I realize CRK and SAS are different in many important fundamental respects.
However, some of those different factors are actually in CRK’s favor.

What do you know about SAS that makes it so compelling that I should pay
2.5 X as much for its (43-101 compliant) gold?